Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
OnkoRisk Hereditary Oncology Management Panel BioReference Health United States | 47 | 17 |
|
OnkoRisk Hereditary Oncology Guideline Panel BioReference Health United States | 71 | 54 |
|
OnkoRisk Women's Hereditary Cancer Panel BioReference Health United States | 34 | 18 |
|
OnkoRisk Hereditary Urology Panel BioReference Health United States | 27 | 19 |
|
BioReference Health United States | 4 | 2 |
|
OnkoSight Advanced Bladder Cancer Panel BioReference Health United States | 1 | 39 |
|
OnkoSight Advanced Breast Cancer Panel BioReference Health United States | 1 | 50 |
|
BioReference Health United States | 1 | 75 |
|
BioReference Health United States | 1 | 1 |
|
POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE BioReference Health United States | 1 | 1 |
|
BioReference Health United States | 1 | 1 |
|
BioReference Health United States | 1 | 1 |
|
ALPORT SYNDROME, AUTOSOMAL RECESSIVE BioReference Health United States | 1 | 1 |
|
BioReference Health United States | 1 | 1 |
|
CARNITINE PALMITOYLTRANSFERASE DEFICIENCY, TYPE 2 BioReference Health United States | 1 | 1 |
|
BioReference Health United States | 1 | 1 |
|
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA BioReference Health United States | 1 | 1 |
|
DEAFNESS, AUTOSOMAL RECESSIVE 1A BioReference Health United States | 1 | 1 |
|
FACTOR XI DEFICIENCY (HEMOPHILIA C) BioReference Health United States | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.